Phase 2 Study of KHK4577

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions

Atopic Dermatitis

Interventions

DRUG

KHK4577

DRUG

Placebo

Trial Locations (1)

For additional information regarding investigative sites for this trial, contact Kyowa Hakko Kirin, Sapporo

All Listed Sponsors

lead

Kyowa Kirin Co., Ltd.

INDUSTRY

NCT02004119 - Phase 2 Study of KHK4577 | Biotech Hunter | Biotech Hunter